独立行政法人国立病院機構南岡山医療センターは、岡山県都窪郡早島町にある医療機関である。

During the past decade, National Hospital Organization Minami-Okayama Medical Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Minami-Okayama Medical Center" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Minami-Okayama Medical Center" are "Alzheimer Disease" (3 trials), "Nervous System Diseases" (2 trials) and "Idiopathic Interstitial Pneumonia" (1 trials). Many other conditions were trialed in "National Hospital Organization Minami-Okayama Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Minami-Okayama Medical Center" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "SHP615" (2 trials), "bapineuzumab" (2 trials), "placebo" (2 trials), "Bapineuzumab 0.5 mg/kg" (1 trials) and "MHOS/SHP615" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Minami-Okayama Medical Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Minami-Okayama Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in National Hospital Organization Minami-Okayama Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Minami-Okayama Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".